Psych MEQs / SAQs · Consultation-liaison psychiatry
TBI psychiatry — depression, aggression, capacity (MEQ)
FRANZCP-style MEQ on post-TBI depression, aggression ladder including beta-blockers, personality change framing, and decision-specific capacity.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Formulation. Concurrent syndromes: (1) major depression due to another medical condition (TBI) — anhedonia, insomnia, passive SI months after moderate injury; depression is common and outcome-relevant after TBI.[1] (2) Aggression/behavioural dyscontrol linked to bifrontal injury and frustration intolerance — clinical correlates include frontal pathology and mood comorbidity.[5] (3) Features of personality change due to another medical condition (disinhibition, not himself) that may coexist with depression and must not be collapsed into "just depression" or primary personality disorder.[6] Not established primary schizophrenia; not day-3 PTA only (now 5 months).
(ii) Management. Depression: adapted psychotherapy + SSRI. Sertraline is the most trial-visible agent (Fann treatment RCT; Jorge prevention RCT) — start 25–50 mg oral daily, titrate, monitor suicide risk, hyponatraemia, interactions; avoid bupropion if seizure concern.[2][3] Aggression: medical/environmental review first; behavioural structure with rehab team. Prefer beta-blockers (e.g. propranolol low-and-slow with BP/HR monitoring) per expert recommendations rather than standing high-dose olanzapine for non-psychotic dyscontrol; reserve low-dose short-term atypical antipsychotic only for imminent danger; avoid chronic benzo/anticholinergic strategies.[4][5][6]
(iii) Capacity. Decision-specific analysis of the business sale: understanding, retaining, weighing, communicating. Brief cognitive screen 28/30 does not prove executive weighing for a complex financial act; frontal disinhibition and depression both threaten valid consent. Pause major transactions, involve appropriate legal substitute pathways under local law, reassess after treatment and with neuropsychology if needed.[6]
(iv) Disposition and risk. Active suicide risk plan; violence/impulse risk on unit and at home; substance screen; family education; stepwise rehab and community CL/neuropsychiatry follow-up; driving/work fitness deferred until team clearance; document least-restrictive legal status if needed.[1][6]
Common errors
Collapsing everything into primary personality disorder; standing high-dose olanzapine without beta-blocker consideration; equating MMSE-like scores with complex financial capacity; ignoring suicide risk in post-TBI depression.[1][4][6]
Examiner notes
Reward dual diagnosis of depression + personality change, named sertraline trials, beta-blocker priority, and sophisticated capacity reasoning.[2][3][4]
References
- [1]Bombardier CH, Fann JR, Temkin NR, et al. Rates of major depressive disorder and clinical outcomes following traumatic brain injury JAMA, 2010.PMID 20483970
- [2]Fann JR, Bombardier CH, Temkin N, et al. Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial J Head Trauma Rehabil, 2017.PMID 28520672
- [3]Jorge RE, Acion L, Burin DI, et al. Sertraline for Preventing Mood Disorders Following Traumatic Brain Injury: A Randomized Clinical Trial JAMA Psychiatry, 2016.PMID 27626622
- [4]Plantier D, Luauté J, SOFMER group Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice Ann Phys Rehabil Med, 2016.PMID 26797170
- [5]Tateno A, Jorge RE, Robinson RG Clinical correlates of aggressive behavior after traumatic brain injury J Neuropsychiatry Clin Neurosci, 2003.PMID 12724455
- [6]Rao V, Koliatsos V, Ahmed F, et al. Neuropsychiatric disturbances associated with traumatic brain injury: a practical approach to evaluation and management Semin Neurol, 2015.PMID 25714869